Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B: Results of a randomized multicenter trial
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 20 (2) , 168-174
- https://doi.org/10.1016/s0168-8278(05)80054-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis BJournal of Hepatology, 1989
- A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in ItalyHepatology, 1989
- Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigenHepatology, 1989
- Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.Gut, 1989
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.Gut, 1987
- Recombinant Leukocyte A Interferon Treatment in Patients With Chronic Hepatitis B Virus InfectionGastroenterology, 1985
- Survival in Chronic Hepatitis BAnnals of Internal Medicine, 1984
- Spontaneous Disappearance of Viral Replication and Liver Cell Inflammation in Hbsag–Positive Chronic Active Hepatitis: Results of A Placebo Vs. Interferon TrialHepatology, 1982